$OSCR

Explicit claim • strong conviction • basis: price target upside

we're going to see a rebound to 30, maybe even 35 and I think on the very very high side of things, I think we could see Oscar go to $40 per share

Explicit claim • strong conviction • basis: multiple relative

Moving on to Oscar Healthier, another one of those names where I do think it's still cheap. If they do achieve their own guidance for 2026, which in the interview I had with CEO, seems like they're going to meet it. Stock is cheap. You'll see a re-rating.

Explicit claim • strong conviction • basis: fair value gap

DCF model values the stock at $29.83 per share.

Explicit claim • strong conviction • basis: explicit term

So, I clearly had the technical skill to understand that Oscar was wrongly priced. But here is the problem. I know a lot about valuation. I even invented my own method to value companies, but I know absolutely nothing about the US healthcare system. It's completely outside my circle of competence and I had no idea how the government policy could impact Oscar. So when the stock price kept dropping, I started doubting my own assumptions. I was not able to hold a company I did not fully understand. I end up selling at $13.73, taking a tiny 4% profit. Today is trading around $29.